Hello, and welcome, everyone, to the Cencora Q1 fiscal year 2025 earnings call. My name is Becky, and I'll be your operator today. (Operator Instructions) I will now hand over to your host, Head of ...

Reconciliations of these measures to GAAP are provided in today’s press release, which is available on our website at investor.cencora.com. We’ve also posted a slide presentation to accompany ...

Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year to $81.5 billion. On the basis of U.S. generally ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with two PharmaLex experts about navigating complex R&D ...

Cencora is one of the world's largest pharmaceutical ... Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money ...

Investors in Cencora Inc (Symbol ... publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would ...

Black Kite’s 6th annual Third Party Breach Report reveals that healthcare organizations, responsible for 41.2% of third-party ...

Black Kite, the leader in third-party cyber risk intelligence, today published its sixth annual Third Party Breach Report, which provides deep analysis of public breaches and regulatory filings from ...

Q4 2024 Earnings Conference Call January 30, 2025 8:00 AM ETCompany ParticipantsAlexandra Deignan – Head-Investor Relations ...

Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...